Discover the versatile potential of Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate, a powerful small molecule drug that has demonstrated remarkable anti-cancer and anti-infectious properties. This compound, with its unique CAS number 1443979-21-2, boasts a molecular weight of 330.26g/mol and a purity of at least 95%. Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate targets the cell wall and extracellular matrix of various cancer cells, inhibiting the synthesis of disulfide bonds and disrupting energy metabolism. Its versatility extends to reducing the replication of HIV-1 and herpes simplex virus, making it a valuable asset in the fight against infectious diseases. Unlock the potential of this exceptional chemical in your research and development endeavors, where precision and performance are paramount.
Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate is a remarkable small molecule drug that has demonstrated remarkable potential in the fight against various types of cancer. This compound, identified by the CAS number 1443979-21-2, is a meticulously crafted chemical entity that holds the key to unlocking new frontiers in cancer research and treatment.
At the heart of this compound's potency lies its unique ability to target and disrupt the fundamental processes that sustain cancer cell growth and proliferation. Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate has been shown to bind to cellulose and crystalline cellulose, which are integral components of the cell wall and extracellular matrix in many cancer cells. By interfering with these structural elements, the compound effectively inhibits the synthesis of disulfide bonds in protein chains, a crucial process for the survival and proliferation of cancer cells.
But the compound's versatility extends beyond its anti-cancer properties. Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate has also demonstrated promising anti-infectious disease capabilities, exhibiting the ability to reduce the replication of human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus. This multifaceted approach to tackling both cancer and infectious diseases underscores the remarkable potential of this compound to revolutionize the field of biomedical research and therapeutics.
To delve deeper into the technical details, applications, and safety guidelines of Trifluoroacetic acid ethyl 2-(morpholin-3-ylformamido)acetate, we encourage you to consult the relevant scientific literature, technical documents, and other resources available. These materials will provide you with a comprehensive understanding of this remarkable compound and its potential to transform the landscape of cancer research and treatment, as well as the fight against infectious diseases.